Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11075)
All Articles published online
|
Publishing Process of This Article
|
Apr 14, 2014 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pernot S, Terme M, Voron T, Colussi O, Marcheteau E, Tartour E, Taieb J. Colorectal cancer and immunity: What we know and perspectives. World J Gastroenterol 2014; 20(14): 3738-3750 [PMID: 24833840 DOI: 10.3748/wjg.v20.i14.3738] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i14/3738.htm |
| Number | Citing Articles |
| 1 |
Olga Nigro, Claudio Chini, Ilaria Proserpio. Molecularly targeted therapy for advanced gastrointestinal noncolorectal cancer treatment: how to choose? Past, present, future. Anti-Cancer Drugs 2021; 32(6): 593 doi: 10.1097/CAD.0000000000001071
|
| 2 |
Matej Horvat, Uroš Potočnik, Katja Repnik, Rajko Kavalar, Borut Štabuc. Single Nucleotide Polymorphisms as Prognostic and Predictive Factors of Adjuvant Chemotherapy in Colorectal Cancer of Stages I and II. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/2139489
|
| 3 |
Allison A. Aka, Jeff A. Rappaport, Amanda M. Pattison, Takami Sato, Adam E. Snook, Scott A. Waldman. Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer. Expert Review of Clinical Pharmacology 2017; 10(5): 549 doi: 10.1080/17512433.2017.1292124
|
| 4 |
Nikolai Klebanov, Mykyta Artomov, William B. Goggins, Emma Daly, Mark J. Daly, Hensin Tsao. Burden of unique and low prevalence somatic mutations correlates with cancer survival. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-41015-5
|
| 5 |
Qiao Meng, Yang Zhao, Miao Xu, Pingzhang Wang, Jun Li, Rongli Cui, Weiwei Fu, Shigang Ding. Increased circulating regulatory T cells and decreased follicular T helper cells are associated with colorectal carcinogenesis. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1287632
|
| 6 |
Edward S. Taylor, John L. McCall, Adam Girardin, Fran M. Munro, Michael A. Black, Roslyn A. Kemp. Functional impairment of infiltrating T cells in human colorectal cancer. OncoImmunology 2016; 5(11): e1234573 doi: 10.1080/2162402X.2016.1234573
|
| 7 |
Lei Yu, Miao-Miao Zhang, Ji-Guang Hou. Molecular and cellular pathways in colorectal cancer: apoptosis, autophagy and inflammation as key players. Scandinavian Journal of Gastroenterology 2022; 57(11): 1279 doi: 10.1080/00365521.2022.2088247
|
| 8 |
Nor Adzimah Johdi, Nur Fazilah Sukor. Colorectal Cancer Immunotherapy: Options and Strategies. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01624
|
| 9 |
Solène Gatault, Marie Delbeke, Virginie Driss, Aurore Sarazin, Arnaud Dendooven, Jean-Emmanuel Kahn, Guillaume Lefèvre, Monique Capron. IL-18 Is Involved in Eosinophil-Mediated Tumoricidal Activity against a Colon Carcinoma Cell Line by Upregulating LFA-1 and ICAM-1. The Journal of Immunology 2015; 195(5): 2483 doi: 10.4049/jimmunol.1402914
|
| 10 |
Camille A. Spinner, Isabelle Lamsoul, Arnaud Métais, Chanaëlle Febrissy, Christel Moog-Lutz, Pierre G. Lutz. The E3 Ubiquitin Ligase Asb2α in T Helper 2 Cells Negatively Regulates Antitumor Immunity in Colorectal Cancer. Cancer Immunology Research 2019; 7(8): 1332 doi: 10.1158/2326-6066.CIR-18-0562
|
| 11 |
Pauline Zaenker, Johnny Lo, Robert Pearce, Phillip Cantwell, Lester Cowell, Mark Lee, Christopher Quirk, Henry Law, Elin Gray, Mel Ziman. A diagnostic autoantibody signature for primary cutaneous melanoma. Oncotarget 2018; 9(55): 30539 doi: 10.18632/oncotarget.25669
|
| 12 |
Joke Tommelein, Laurine Verset, Tom Boterberg, Pieter Demetter, Marc Bracke, Olivier De Wever. Cancer-Associated Fibroblasts Connect Metastasis-Promoting Communication in Colorectal Cancer. Frontiers in Oncology 2015; 5 doi: 10.3389/fonc.2015.00063
|
| 13 |
Natasja De Vries, Marloes Swets, Alexander Vahrmeijer, Marianne Hokland, Peter Kuppen. The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and Treatment. International Journal of Molecular Sciences 2016; 17(7): 1030 doi: 10.3390/ijms17071030
|
| 14 |
Wei Wang, Mingxing Liu, Yang Wang, Tao Yang, Dongsheng Li, Feng Ding, Hongzhi Sun, Guang Bai, Qing Li, Chang G. Son. Lycium barbarum Polysaccharide Promotes Maturation of Dendritic Cell via Notch Signaling and Strengthens Dendritic Cell Mediated T Lymphocyte Cytotoxicity on Colon Cancer Cell CT26‐WT. Evidence-Based Complementary and Alternative Medicine 2018; 2018(1) doi: 10.1155/2018/2305683
|
| 15 |
Amy I. Yu, Lili Zhao, Kathryn A. Eaton, Sharon Ho, Jiachen Chen, Sara Poe, James Becker, Allison Gonzalez, Delaney McKinstry, Muneer Hasso, Jonny Mendoza-Castrejon, Joel Whitfield, Charles Koumpouras, Patrick D. Schloss, Eric C. Martens, Grace Y. Chen. Gut Microbiota Modulate CD8 T Cell Responses to Influence Colitis-Associated Tumorigenesis. Cell Reports 2020; 31(1): 107471 doi: 10.1016/j.celrep.2020.03.035
|
| 16 |
Martha Montserrat Rangel-Sosa, Estuardo Aguilar-Córdova, Augusto Rojas-Martínez. Inmunoterapia y terapia génica como nuevos tratamientos contra el cáncer. Colombia Medica 2017; 48(3): 138 doi: 10.25100/cm.v48i3.2997
|
| 17 |
Si-yuan You, Wen Rui, Shuai-tong Chen, Hong-ce Chen, Xia-wan Liu, Jun Huang, Hong-yuan Chen. Process of immunogenic cell death caused by disulfiram as the anti-colorectal cancer candidate. Biochemical and Biophysical Research Communications 2019; 513(4): 891 doi: 10.1016/j.bbrc.2019.03.192
|
| 18 |
Peter G. Alexander, Donald C. McMillan, James H. Park. The local inflammatory response in colorectal cancer – Type, location or density? A systematic review and meta-analysis. Cancer Treatment Reviews 2020; 83: 101949 doi: 10.1016/j.ctrv.2019.101949
|
| 19 |
Peng Ye, Yiran Wang, Ruiqi Li, Wanlu Chen, Lu Wan, Peiling Cai. The HER family as therapeutic targets in colorectal cancer. Critical Reviews in Oncology/Hematology 2022; 174: 103681 doi: 10.1016/j.critrevonc.2022.103681
|
| 20 |
Muhammed A. Bakhrebah, Mohammad Nasrullah, Wesam H. Abdulaal, Mohammed A. Hassan, Halima Siddiqui, Huda A. Al Doghaither, Ulfat M. Omar, Nawal Helmi, Mohannad M. Fallatah, Ayat B. Al-Ghafari, Mohammad Imran Khan, Hani Choudhry. High Expression of Pd-1 in Circulating Cells of Patients With Advanced Colorectal Cancer Receiving Adjuvant Therapy. Technology in Cancer Research & Treatment 2020; 19 doi: 10.1177/1533033820969446
|
| 21 |
Taxiarchis Konstantinos Nikolouzakis, Emmanuel Chrysos, Anca Oana Docea, Persefoni Fragkiadaki, John Souglakos, John Tsiaoussis, Aristidis Tsatsakis. Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy. Cancers 2024; 16(11): 1995 doi: 10.3390/cancers16111995
|
| 22 |
Miroslav Hodek, Igor Sirák, Alexander Ferko, Július Örhalmi, Eva Hovorková, Dimitar Hadži Nikolov, Petr Paluska, Jindřich Kopecký, Jiří Petera, Milan Vošmik. Neoadjuvant chemoradiotherapy of rectal carcinoma. Strahlentherapie und Onkologie 2016; 192(9): 632 doi: 10.1007/s00066-016-0988-6
|
| 23 |
Amanda N. Lisby, John C. Flickinger, Babar Bashir, Megan Weindorfer, Sanjna Shelukar, Madison Crutcher, Adam E. Snook, Scott A. Waldman. GUCY2C as a biomarker to target precision therapies for patients with colorectal cancer. Expert Review of Precision Medicine and Drug Development 2021; 6(2): 117 doi: 10.1080/23808993.2021.1876518
|
| 24 |
Jeng‐Kai Jiang, Chi‐Hung Lin, Ting‐An Chang, Liang‐Chuan Lo, Chien‐Ping Lin, Ruey‐Hwa Lu, Chih‐Yung Yang. Decreased interleukin‐17RA expression is associated with good prognosis in patients with colorectal cancer and inhibits tumor growth and vascularity in mice. Cancer Medicine 2024; 13(5) doi: 10.1002/cam4.7059
|
| 25 |
Yuanyuan Zhang, Lei zhang, Hongru Sun, Ying Liu, Jing Xu, Hao Huang, Jinming Fu, Ding Zhang, Tian Tian, Yashuang Zhao, Guiyu Wang. Inhibitory immune checkpoints PDCD-1 and LAG-3 hypermethylation may reduce the risk of colorectal cancer. Molecular Medicine 2021; 27(1) doi: 10.1186/s10020-021-00373-5
|
| 26 |
Brett Bell, Kevin Flores-Lovon, Luis A. Cueva-Chicaña, Rodney Macedo. Chemokine Receptors in Health and Disease. International Review of Cell and Molecular Biology 2024; 388: 20 doi: 10.1016/bs.ircmb.2024.02.003
|
| 27 |
Caterina Fattorini, Marco Arganini, Andrea Cavazzana, Maria Raffaella Ambrosio. Gastrointestinal Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2022; 4: 187 doi: 10.1007/16833_2022_26
|
| 28 |
Jonna Berntsson, Maria C Svensson, Karin Leandersson, Björn Nodin, Patrick Micke, Anna H Larsson, Jakob Eberhard, Karin Jirström. The clinical impact of tumour‐infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: A cohort study. International Journal of Cancer 2017; 141(8): 1654 doi: 10.1002/ijc.30869
|
| 29 |
Zahra Payandeh, Saeed Khalili, Mohammad Hossein Somi, Maysam Mard‐Soltani, Amir Baghbanzadeh, Khalil Hajiasgharzadeh, Nasser Samadi, Behzad Baradaran. PD‐1/PD‐L1‐dependent immune response in colorectal cancer. Journal of Cellular Physiology 2020; 235(7-8): 5461 doi: 10.1002/jcp.29494
|
| 30 |
Alexander B. Dillon, Kevin Lin, Andrew Kwong, Susana Ortiz. Immunotherapy in Melanoma, Gastrointestinal (GI), and Pulmonary Malignancies. AIMS Public Health 2015; 2(1): 86 doi: 10.3934/publichealth.2015.1.86
|
| 31 |
Keehoon Jung, Takahiro Heishi, Omar F. Khan, Piotr S. Kowalski, Joao Incio, Nuh N. Rahbari, Euiheon Chung, Jeffrey W. Clark, Christopher G. Willett, Andrew D. Luster, Seok Hyun Yun, Robert Langer, Daniel G. Anderson, Timothy P. Padera, Rakesh K. Jain, Dai Fukumura. Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy. Journal of Clinical Investigation 2017; 127(8): 3039 doi: 10.1172/JCI93182
|
| 32 |
Jian Liu, Lei Wang, Tongqing Wang, Jizheng Wang. Expression of IL-23R and IL-17 and the pathology and prognosis of urinary bladder carcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.9145
|
| 33 |
Mosar Corrêa Rodrigues, José Athayde Vasconcelos Morais, Rayane Ganassin, Giulia Rosa Tavares Oliveira, Fabiana Chagas Costa, Amanda Alencar Cabral Morais, Ariane Pandolfo Silveira, Victor Carlos Mello Silva, João Paulo Figueiró Longo, Luis Alexandre Muehlmann. An Overview on Immunogenic Cell Death in Cancer Biology and Therapy. Pharmaceutics 2022; 14(8): 1564 doi: 10.3390/pharmaceutics14081564
|
| 34 |
Jiwei Wang, Song Li, Honglang Li, Xiaoshuang Zhou, Huabin Wen, Bin Lai. IRF4 overexpression promotes the transdifferentiation of tregs into macrophage‐like cells to inhibit the development of colon cancer. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01766-6
|
| 35 |
Héctor Randhall Callata-Carhuapoma, Jesús García-Foncillas López. Textbook of Gastrointestinal Oncology. 2019; : 465 doi: 10.1007/978-3-030-18890-0_26
|
| 36 |
Rubén Varela-Calviño, Oscar J Cordero. Stem and immune cells in colorectal primary tumour: Number and function of subsets may diagnose metastasis. World Journal of Immunology 2015; 5(2): 68-77 doi: 10.5411/wji.v5.i2.68
|
| 37 |
Martyna Bednarczyk, Małgorzata Muc-Wierzgoń, Katarzyna Walkiewicz, Teresa Kokot, Edyta Fatyga, Urszula Mazurek. Profile of gene expression of TLR-signaling pathways in colorectal cancer tissues. International Journal of Immunopathology and Pharmacology 2017; 30(3): 322 doi: 10.1177/0394632017716048
|
| 38 |
Oliver Ingo Hoffmann, Christian Ilmberger, Stefanie Magosch, Mareile Joka, Karl-Walter Jauch, Barbara Mayer. Impact of the spheroid model complexity on drug response. Journal of Biotechnology 2015; 205: 14 doi: 10.1016/j.jbiotec.2015.02.029
|
| 39 |
Ajay Prakash, Travis Gates, Xianda Zhao, Dechen Wangmo, Subbaya Subramanian. Tumor-derived extracellular vesicles in the colorectal cancer immune environment and immunotherapy. Pharmacology & Therapeutics 2023; 241: 108332 doi: 10.1016/j.pharmthera.2022.108332
|
| 40 |
Yang Zhang, Jing Gao, Xia Wang, Shaorong Deng, Hao Ye, Wen Guan, Mingyuan Wu, Shunying Zhu, Yan Yu, Wei Han. CXCL4 mediates tumor regrowth after chemotherapy by suppression of antitumor immunity. Cancer Biology & Therapy 2015; 16(12): 1775 doi: 10.1080/15384047.2015.1095404
|
| 41 |
María Florencia Pansa, María Julia Lamberti, Ingrid Sol Cogno, Silvia Graciela Correa, Natalia Belén Rumie Vittar, Viviana Alicia Rivarola. Contribution of resident and recruited macrophages to the photodynamic intervention of colorectal tumor microenvironment. Tumor Biology 2016; 37(1): 541 doi: 10.1007/s13277-015-3768-5
|
| 42 |
Pierpaolo Correale, Cirino Botta, Domenico Ciliberto, Pierpaolo Pastina, Rossana Ingargiola, Silvia Zappavigna, Pierfrancesco Tassone, Luigi Pirtoli, Michele Caraglia, Pierosandro Tagliaferri. Immunotherapy of Colorectal Cancer: New Perspectives After a Long Path. Immunotherapy 2016; 8(11): 1281 doi: 10.2217/imt-2016-0089
|
| 43 |
Jeffrey A. Rappaport, Scott A. Waldman. An update on guanylyl cyclase C in the diagnosis, chemoprevention, and treatment of colorectal cancer. Expert Review of Clinical Pharmacology 2020; 13(10): 1125 doi: 10.1080/17512433.2020.1826304
|
| 44 |
Mircea Chirica, Lionel Le Bourhis, Jacqueline Lehmann-Che, Victor Chardiny, Fatiha Bouhidel, Laure Foulboeuf, Jean Marc Gornet, Nelson Lourenco, Nicolas Dulphy, Antoine Toubert, Matthieu Allez. Phenotypic analysis of T cells infiltrating colon cancers: Correlations with oncogenetic status. OncoImmunology 2015; 4(8): e1016698 doi: 10.1080/2162402X.2015.1016698
|
| 45 |
Katia Lemdani, Nathalie Mignet, Vincent Boudy, Johanne Seguin, Edward Oujagir, Olivia Bawa, Frédérique Peschaud, Jean-François Emile, Claude Capron, Robert Malafosse. Local immunomodulation combined to radiofrequency ablation results in a complete cure of local and distant colorectal carcinoma. OncoImmunology 2019; 8(3): 1550342 doi: 10.1080/2162402X.2018.1550342
|
| 46 |
Paulina Pathria, Dagmar Gotthardt, Michaela Prchal-Murphy, Eva-Maria Putz, Martin Holcmann, Michaela Schlederer, Beatrice Grabner, Ilija Crncec, Jasmin Svinka, Monica Musteanu, Thomas Hoffmann, Martin Filipits, Walter Berger, Valeria Poli, Lukas Kenner, Martin Bilban, Emilio Casanova, Mathias Müller, Birgit Strobl, Editha Bayer, Thomas Mohr, Veronika Sexl, Robert Eferl. MyeloidSTAT3promotes formation of colitis-associated colorectal cancer in mice. OncoImmunology 2015; 4(4): e998529 doi: 10.1080/2162402X.2014.998529
|
| 47 |
Theodoros Argyropoulos, Periklis G. Foukas, Effrosyni Karakitsou, Stefanos Konstantoudakis, Maria Kefala, Nektarios Koufopoulos, Nikolaos Machairas, Ioannis Panayiotides, Konstantinos Triantafyllou. Predictive Value of CD3, CD8, CD45RO Expression in Stage II/III Colorectal Cancer. International Journal of Reliable and Quality E-Healthcare 2018; 7(3): 18 doi: 10.4018/IJRQEH.2018070102
|
| 48 |
S. Stremitzer, J. Stift, J. Singh, P. Starlinger, B. Gruenberger, D. Tamandl, T. Gruenberger. Histological response, pattern of tumor destruction and clinical outcome after neoadjuvant chemotherapy including bevacizumab or cetuximab in patients undergoing liver resection for colorectal liver metastases. European Journal of Surgical Oncology (EJSO) 2015; 41(7): 868 doi: 10.1016/j.ejso.2015.03.223
|
| 49 |
Yu Zhou, Jun-quan Liu, Zhong-hai Zhou, Xiao-ting LV, Yong-qiang Chen, Lei-qing Sun, Fu-xing Chen. Enhancement of CD3AK cell proliferation and killing ability by α-Thujone. International Immunopharmacology 2016; 30: 57 doi: 10.1016/j.intimp.2015.11.027
|
| 50 |
Marco Puzzoni, Nicola Silvestris, Francesco Leone, Riccardo Giampieri, Luca Faloppi, Laura Demurtas, Emanuela Dell’Aquila, Donatella Marino, Oronzo Brunetti, Silvio Ken Garattini, Elena Ongaro, Giorgio Astara, Laura Orgiano, Giuseppe Aprile, Daniele Santini, Mario Scartozzi. The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following?. Targeted Oncology 2016; 11(5): 593 doi: 10.1007/s11523-016-0437-6
|
| 51 |
Letizia Procaccio, Marta Schirripa, Matteo Fassan, Loredana Vecchione, Francesca Bergamo, Alessandra Anna Prete, Rossana Intini, Chiara Manai, Vincenzo Dadduzio, Alice Boscolo, Vittorina Zagonel, Sara Lonardi. Immunotherapy in Gastrointestinal Cancers. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/4346576
|
| 52 |
Jian-Xin Ma, Li Qian, Yan Zhou. Stimulation effect of chitosan on the immunity of radiotherapy patients suffered from lung cancer. International Journal of Biological Macromolecules 2015; 72: 195 doi: 10.1016/j.ijbiomac.2014.08.027
|
| 53 |
Imke Atreya, Markus Kindermann, Stefan Wirtz. Innate lymphoid cells in intestinal cancer development. Seminars in Immunology 2019; 41: 101267 doi: 10.1016/j.smim.2019.02.001
|
| 54 |
Maria L. Wikberg, Agnes Ling, Xingru Li, Åke Öberg, Sofia Edin, Richard Palmqvist. Neutrophil infiltration is a favorable prognostic factor in early stages of colon cancer. Human Pathology 2017; 68: 193 doi: 10.1016/j.humpath.2017.08.028
|
| 55 |
Yan Li, Hailin Lu, Yongchun Gu, Zhiqiang Ning, Tinghua Cao, Chao Chen, Chengru Hu, Min Tao. Enhancement of NK cells proliferation and function by Shikonin. Immunopharmacology and Immunotoxicology 2017; 39(3): 124 doi: 10.1080/08923973.2017.1299174
|
| 56 |
Boon Yean Chai, Wai Kien Yip, Noraini Dusa, Norhafizah Mohtarrudin, Heng Fong Seow. Loss of Interleukin-17RA Expression is Associated with Tumour Progression in Colorectal Carcinoma. Pathology & Oncology Research 2020; 26(4): 2291 doi: 10.1007/s12253-020-00820-4
|
| 57 |
Sandrine Nugteren, Jeroen A.C.M. Goos, Pien M. Delis-van Diemen, Ytje Simons-Oosterhuis, Dicky J. Lindenbergh-Kortleve, Daniëlle H. van Haaften, Joyce Sanders, Gerrit A. Meijer, Remond J.A. Fijneman, Janneke N. Samsom. Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis. OncoImmunology 2020; 9(1) doi: 10.1080/2162402X.2020.1832761
|
| 58 |
Yong-Hong Huang, Yun-Fei Cao, Zhi-Yuan Jiang, Sen Zhang, Feng Gao. Th22 cell accumulation is associated with colorectal cancer development. World Journal of Gastroenterology 2015; 21(14): 4216-4224 doi: 10.3748/wjg.v21.i14.4216
|
| 59 |
Julie Jacobs, Evelien Smits, Filip Lardon, Patrick Pauwels, Vanessa Deschoolmeester. Immune Checkpoint Modulation in Colorectal Cancer: What’s New and What to Expect. Journal of Immunology Research 2015; 2015: 1 doi: 10.1155/2015/158038
|
| 60 |
Qingling Hua, Yanzhe Zhu, Hu Liu, Xiaobing Ye. Diabetes and the risk of biochemical recurrence in patients with treated localized prostate cancer: a meta-analysis. International Urology and Nephrology 2016; 48(9): 1437 doi: 10.1007/s11255-016-1316-x
|
| 61 |
Fabian Haak, Isabelle Obrecht, Nadia Tosti, Benjamin Weixler, Robert Mechera, Silvio Däster, Marco von Strauss, Tarik Delko, Giulio C. Spagnoli, Luigi Terracciano, Giuseppe Sconocchia, Markus von Flüe, Marko Kraljević, Raoul A. Droeser. Tumor Infiltration by OX40+ Cells Enhances the Prognostic Significance of CD16+ Cell Infiltration in Colorectal Cancer. Cancer Control 2020; 27(1) doi: 10.1177/1073274820903383
|
| 62 |
Julien Taïeb, Thierry André, Farid El Hajbi, Emilie Barbier, Clémence Toullec, Stefano Kim, Olivier Bouche, Frederic Di Fiore, Marion Chauvenet, Hervé Perrier, Ludovic Evesque, Pierre Laurent-Puig, Jean-François Emile, Jérémie Bez, Côme Lepage, David Tougeron. Avelumab versus standard second line treatment chemotherapy in metastatic colorectal cancer patients with microsatellite instability: The SAMCO-PRODIGE 54 randomised phase II trial. Digestive and Liver Disease 2021; 53(3): 318 doi: 10.1016/j.dld.2020.11.031
|
| 63 |
Julie Bonnereau, Tristan Courau, Nicolas Asesio, Delphine Salfati, Fatiha Bouhidel, Hélène Corte, Sarah Hamoudi, Nassim Hammoudi, Julie Lavolé, Justine Vivier-Chicoteau, Victor Chardiny, Leon Maggiori, Mathieu Blery, Romain Remark, Cécile Bonnafous, Pierre Cattan, Antoine Toubert, Purnima Bhat, Matthieu Allez, Thomas Aparicio, Lionel Le Bourhis. Autologous T cell responses to primary human colorectal cancer spheroids are enhanced by ectonucleotidase inhibition. Gut 2023; 72(4): 699 doi: 10.1136/gutjnl-2021-326553
|
| 64 |
Barry Paul, Bert H O’Neil, Autumn J McRee. Checkpoint Inhibition for Colorectal Cancer: Progress and Possibilities. Immunotherapy 2016; 8(6): 693 doi: 10.2217/imt-2016-0013
|
| 65 |
Jing Lin, Yuwei Wu, Guangde Liu, Rui Cui, Youhua Xu. Advances of ultrasound in tumor immunotherapy. International Immunopharmacology 2024; 134: 112233 doi: 10.1016/j.intimp.2024.112233
|
| 66 |
Agnes Ling, Anna Löfgren-Burström, Pär Larsson, Xingru Li, Maria L. Wikberg, Åke Öberg, Roger Stenling, Sofia Edin, Richard Palmqvist. TAP1 down-regulation elicits immune escape and poor prognosis in colorectal cancer. OncoImmunology 2017; 6(11): e1356143 doi: 10.1080/2162402X.2017.1356143
|
| 67 |
Federica Pecci, Luca Cantini, Alessandro Bittoni, Edoardo Lenci, Alessio Lupi, Sonia Crocetti, Enrica Giglio, Riccardo Giampieri, Rossana Berardi. Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer. Current Treatment Options in Oncology 2021; 22(8) doi: 10.1007/s11864-021-00870-z
|
| 68 |
Johana A. Luna‐Coronell, Klemens Vierlinger, Magdalena Gamperl, Johann Hofbauer, Ingrid Berger, Andreas Weinhäusel. The prostate cancer immunome: In silico functional analysis of antigenic proteins from microarray profiling with IgG. PROTEOMICS 2016; 16(8): 1204 doi: 10.1002/pmic.201500378
|
| 69 |
Alexandre Loktionov. Eosinophils in the gastrointestinal tract and their role in the pathogenesis of major colorectal disorders. World Journal of Gastroenterology 2019; 25(27): 3503-3526 doi: 10.3748/wjg.v25.i27.3503
|
| 70 |
Anil Kumar, Vipasha Gautam, Arushi Sandhu, Kajal Rawat, Antika Sharma, Lekha Saha. Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review. World Journal of Gastrointestinal Surgery 2023; 15(4): 495-519 doi: 10.4240/wjgs.v15.i4.495
|
| 71 |
Junnan Gu, Shenghe Deng, Zhenxing Jiang, Fuwei Mao, Yifan Xue, Le Qin, Jianguo Shi, Jia Yang, Huili Li, Jie Yu, Ke Liu, Ke Wu, Yinghao Cao, Kailin Cai. Modified Naples prognostic score for evaluating the prognosis of patients with obstructive colorectal cancer. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11435-8
|
| 72 |
Iris N. Pardieck, Priscilla A. Jawahier, Marloes Swets, Cornelis J.H. van de Velde, Peter J.K. Kuppen. Novel avenues in immunotherapies for colorectal cancer. Expert Review of Gastroenterology & Hepatology 2016; 10(4): 465 doi: 10.1586/17474124.2016.1122522
|
| 73 |
María Sanchez-Castañón, Tze-Kiong Er, Luis Bujanda, Marta Herreros-Villanueva. Immunotherapy in colorectal cancer: What have we learned so far?. Clinica Chimica Acta 2016; 460: 78 doi: 10.1016/j.cca.2016.06.027
|
| 74 |
Héloïse Proquin, Marlon J. Jetten, Marloes C. M. Jonkhout, Luis Guillermo Garduño-Balderas, Jacob J. Briedé, Theo M. de Kok, Henk van Loveren, Yolanda I. Chirino. Transcriptomics analysis reveals new insights in E171-induced molecular alterations in a mouse model of colon cancer. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-28063-z
|
| 75 |
Yanghua Jie, Xiaobei Yang, Weidong Chen. Pulsatilla Decoction Combined with 5-Fluorouracil Triggers Immunogenic Cell Death in Colorectal Cancer Cells. Cancer Biotherapy and Radiopharmaceuticals 2022; 37(10): 945 doi: 10.1089/cbr.2020.4369
|
| 76 |
E. V. Kulikova, V. V. Kurilin, J. A. Shevchenko, I. A. Obleukhova, E. A. Khrapov, U. A. Boyarskikh, M. L. Filipenko, R. V. Shorokhov, V. K. Yakushenko, A. V. Sokolov, S. V. Sennikov. Dendritic Cells Transfected with a DNA Construct Encoding Tumour‐associated Antigen Epitopes Induce a Cytotoxic Immune Response Against Autologous Tumour Cells in a Culture of Mononuclear Cells from Colorectal Cancer Patients. Scandinavian Journal of Immunology 2015; 82(2): 110 doi: 10.1111/sji.12311
|
| 77 |
T Colangelo, G Polcaro, P Ziccardi, B Pucci, L Muccillo, M Galgani, A Fucci, M R Milone, A Budillon, M Santopaolo, C Votino, M Pancione, A Piepoli, G Mazzoccoli, M Binaschi, M Bigioni, C A Maggi, M Fassan, C Laudanna, G Matarese, L Sabatino, V Colantuoni. Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer. Cell Death & Disease 2016; 7(2): e2120 doi: 10.1038/cddis.2016.28
|
| 78 |
Chiara Marchiori, Melania Scarpa, Andromachi Kotsafti, Susan Morgan, Matteo Fassan, Vincenza Guzzardo, Andrea Porzionato, Imerio Angriman, Cesare Ruffolo, Stefania Sut, Stefano Dall’Acqua, Romeo Bardini, Raffaele De Caro, Carlo Castoro, Marco Scarpa, Ignazio Castagliuolo. Epithelial CD80 promotes immune surveillance of colonic preneoplastic lesions and its expression is increased by oxidative stress through STAT3 in colon cancer cells. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1205-0
|
| 79 |
A. Patsouris, N. Bendriss-Vermare. Facteurs pronostiques et prédictifs de réponse aux immunothérapies (TILs, TAM). Oncologie 2015; 17(9): 397 doi: 10.1007/s10269-015-2548-6
|
| 80 |
Vanessa Deschoolmeester, David Kerr, Patrick Pauwels, Jan B. Vermorken. Immunotherapy for Gastrointestinal Cancer. 2017; : 23 doi: 10.1007/978-3-319-43063-8_2
|
| 81 |
Stephanie Manning, Kirsty M Danielson. The immunomodulatory role of tumor‐derived extracellular vesicles in colorectal cancer. Immunology & Cell Biology 2018; 96(7): 733 doi: 10.1111/imcb.12038
|
| 82 |
Awais Ahmad, Nasir Mahmood, Muhammad Ahtisham Raza, Zarina Mushtaq, Farhan Saeed, Muhammad Afzaal, Muzzamal Hussain, Hafiz Wasiqe Amjad, Hashim Mohammad Al-Awadi. Gut microbiota and their derivatives in the progression of colorectal cancer: Mechanisms of action, genome and epigenome contributions. Heliyon 2024; 10(8): e29495 doi: 10.1016/j.heliyon.2024.e29495
|
| 83 |
Leena Halim, Marco Romano, Reuben McGregor, Isabel Correa, Polychronis Pavlidis, Nathali Grageda, Sec-Julie Hoong, Muhammed Yuksel, Wayel Jassem, Rosalind F. Hannen, Mark Ong, Olivia Mckinney, Bu’Hussain Hayee, Sophia N. Karagiannis, Nicholas Powell, Robert I. Lechler, Estefania Nova-Lamperti, Giovanna Lombardi. An Atlas of Human Regulatory T Helper-like Cells Reveals Features of Th2-like Tregs that Support a Tumorigenic Environment. Cell Reports 2017; 20(3): 757 doi: 10.1016/j.celrep.2017.06.079
|
| 84 |
Victor Hugo Fonseca de Jesus, Tiago Cordeiro Felismino, Milton José de Barros e Silva, Virgílio de Souza e Silva, Rachel P Riechelmann. Current approaches to immunotherapy in noncolorectal gastrointestinal malignancies. Clinics 2018; 73: e510s doi: 10.6061/clinics/2018/e510s
|
| 85 |
Malgorzata E. Wojtowicz, Barbara K. Dunn, Asad Umar. Immunologic approaches to cancer prevention—current status, challenges, and future perspectives. Seminars in Oncology 2016; 43(1): 161 doi: 10.1053/j.seminoncol.2015.11.001
|
| 86 |
Qi Zhang, Franklin G. Berger, Bryan Love, Carolyn E. Banister, Elizabeth A. Murphy, Lorne J. Hofseth. Maternal stress and early-onset colorectal cancer. Medical Hypotheses 2018; 121: 152 doi: 10.1016/j.mehy.2018.09.035
|
| 87 |
David Malka, Astrid Lièvre, Thierry André, Julien Taïeb, Michel Ducreux, Frédéric Bibeau. Immune scores in colorectal cancer: Where are we?. European Journal of Cancer 2020; 140: 105 doi: 10.1016/j.ejca.2020.08.024
|
| 88 |
Caroline Theresa Seebauer, Stefan Brunner, Gabriel Glockzin, Pompiliu Piso, Petra Ruemmele, Hans-Juergen Schlitt, Edward Kenneth Geissler, Stefan Fichtner-Feigl, Rebecca Kesselring. Peritoneal carcinomatosis of colorectal cancer is characterized by structural and functional reorganization of the tumor microenvironment inducing senescence and proliferation arrest in cancer cells. OncoImmunology 2016; 5(12): e1242543 doi: 10.1080/2162402X.2016.1242543
|
| 89 |
Clément R. Rioux, Margie L. Clapper, Harry S. Cooper, Jean Michaud, Natalie St Amant, Hossein Koohsari, Laura Workman, Esther Kaunga, Harvey Hensley, Anthony Pilorget, Catherine Gerard, Hassan Brim. Self-antigen MASH2 combined with the AS15 immunostimulant induces tumor protection in colorectal cancer mouse models. PLOS ONE 2019; 14(1): e0210261 doi: 10.1371/journal.pone.0210261
|
| 90 |
A. A. Tryakin, G. G. Khakimova, T. N. Zabotina, A. A. Borunova, O. A. Malikhova. Modern views on immunological biomarkers of colon cancer. Malignant tumours 2019; 8(4): 50 doi: 10.18027/2224-5057-2018-8-4-50-58
|
| 91 |
Anna Maria Trotta, Alessandro Ottaiano, Carmela Romano, Guglielmo Nasti, Anna Nappi, Chiara De Divitiis, Maria Napolitano, Serena Zanotta, Rossana Casaretti, Crescenzo D'Alterio, Antonio Avallone, Daniela Califano, Rosario Vincenzo Iaffaioli, Stefania Scala. Prospective Evaluation of Cetuximab-Mediated Antibody-Dependent Cell Cytotoxicity in Metastatic Colorectal Cancer Patients Predicts Treatment Efficacy. Cancer Immunology Research 2016; 4(4): 366 doi: 10.1158/2326-6066.CIR-15-0184
|
| 92 |
Katarzyna Jakubowska, Wojciech Kisielewski, Luiza Kańczuga‑Koda, Mariusz Koda, Waldemar Famulski. Stromal and intraepithelial tumor‑infiltrating lymphocytes in colorectal carcinoma. Oncology Letters 2017; doi: 10.3892/ol.2017.7013
|
| 93 |
S. B. Kramar, Yu. V. Soroka, H. O. Havryliuk-Skyba, V. P. Pyda, Z. M. Nebesna, N. Ye. Lisnychuk. Structural changes in the organs of the lymphoid system in terms of induced carcinogenesis. Reports of Morphology 2024; 30(3): 5 doi: 10.31393/morphology-journal-2024-30(3)-01
|
| 94 |
Milan Jovanovic, Nevena Gajovic, Natasa Zdravkovic, Marina Jovanovic, Milena Jurisevic, Danilo Vojvodic, Veljko Maric, Aleksandar Arsenijevic, Ivan Jovanovic. Fecal Galectin-3: A New Promising Biomarker for Severity and Progression of Colorectal Carcinoma. Mediators of Inflammation 2018; 2018: 1 doi: 10.1155/2018/8031328
|
| 95 |
Wang Gang, Jun‐Jie Wang, Rui Guan, Sun Yan, Feng Shi, Jia‐Yan Zhang, Zi‐Meng Li, Jing Gao, Xing‐Li Fu. Strategy to targeting the immune resistance and novel therapy in colorectal cancer. Cancer Medicine 2018; 7(5): 1578 doi: 10.1002/cam4.1386
|
| 96 |
Héloïse Proquin, Marlon J. Jetten, Marloes C.M. Jonkhout, Luis G. Garduño-Balderas, Jacob J. Briedé, Theo M. de Kok, Yolanda I. Chirino, Henk van Loveren. Gene expression profiling in colon of mice exposed to food additive titanium dioxide (E171). Food and Chemical Toxicology 2018; 111: 153 doi: 10.1016/j.fct.2017.11.011
|